Induction of neutralising antibodies by virus-like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza viruses

被引:53
作者
Szecsi, Judit
Boson, Bertrand
Johnsson, Per
Dupeyrot-Lacas, Pia
Matrosovich, Mikhail
Klenk, Hans-Dieter
Klatzmann, David
Volchkov, Viktor
Cosset, Francois-Loic [1 ]
机构
[1] INSERM, U758, F-69007 Lyon, France
[2] Ecole Normale Super Lyon, F-69007 Lyon, France
[3] BioSci Lyon Gerland, IFR128, F-69007 Lyon, France
[4] Epixis SA, F-69007 Lyon, France
[5] Univ Giessen Klinikum, D-35033 Giessen, Germany
[6] Univ Klinikum Marburg, D-35033 Giessen, Germany
[7] Univ Paris 06, Hop La Pitie Salpetriere, Lab Biol & Therapeut Pathol Immunitaires, CNRS,UMR 7087, F-75013 Paris, France
关键词
D O I
10.1186/1743-422X-3-70
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
There is an urgent need to develop novel approaches to vaccination against the emerging, highly pathogenic avian influenza viruses. Here, we engineered influenza viral-like particles ( Flu-VLPs) derived from retroviral core particles that mimic the properties of the viral surface of two highly pathogenic influenza viruses of either H7N1 or H5N1 antigenic subtype. We demonstrate that, upon recovery of viral RNAs from a field strain, one can easily generate expression vectors that encode the HA, NA and M2 surface proteins of either virus and prepare high-titre Flu-VLPs. We characterise these Flu-VLPs incorporating the HA, NA and M2 proteins and we show that they induce high-titre neutralising antibodies in mice.
引用
收藏
页数:7
相关论文
共 35 条
[1]   Genetic characterization of H5N1 influenza A viruses isolated from zoo tigers in Thailand [J].
Amonsin, A ;
Payungporn, S ;
Theamboonlers, A ;
Thanawongnuwech, R ;
Suradhat, S ;
Pariyothorn, N ;
Tantilertcharoen, R ;
Damrongwantanapokin, S ;
Buranathai, C ;
Chaisingh, A ;
Songserm, T ;
Poovorawan, Y .
VIROLOGY, 2006, 344 (02) :480-491
[2]   Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor [J].
Bartosch, B ;
Vitelli, A ;
Granier, C ;
Goujon, C ;
Dubuisson, J ;
Pascale, S ;
Scarselli, E ;
Cortese, R ;
Nicosia, A ;
Cosset, FL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (43) :41624-41630
[3]   In vitro assay for neutralizing antibody to hepatitis C virus:: Evidence for broadly conserved neutralization epitopes [J].
Bartosch, B ;
Bukh, J ;
Meunier, JC ;
Granier, C ;
Engle, RE ;
Blackwelder, WC ;
Emerson, SU ;
Cosset, FL ;
Purcell, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) :14199-14204
[4]   Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes [J].
Bartosch, B ;
Dubuisson, J ;
Cosset, FL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (05) :633-642
[5]   DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant [J].
Bellier, B ;
Dalba, C ;
Clerc, B ;
Desjardins, D ;
Drury, R ;
Cosset, FL ;
Collins, M ;
Klatzmann, D .
VACCINE, 2006, 24 (14) :2643-2655
[6]   Inhibition of release of lentivirus particles with incorporated human influenza virus haemagglutinin by binding to sialic acid-containing cellular receptors [J].
Bosch, V ;
Kramer, B ;
Pfeiffer, T ;
Stärck, L ;
Steinhauer, DA .
JOURNAL OF GENERAL VIROLOGY, 2001, 82 :2485-2494
[7]  
Bucher D., 1975, INFLUENZA VIRUSES IN, P83
[8]   Avian flu special: Is this our best shot? [J].
Check, E .
NATURE, 2005, 435 (7041) :404-406
[9]   Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines [J].
Duisit, G ;
Salvetti, A ;
Moullier, P ;
Cosset, FL .
HUMAN GENE THERAPY, 1999, 10 (02) :189-200
[10]  
FRANCIS T Jr, 1953, Bull World Health Organ, V8, P725